Nantahala Capital Management, LLC Exact Sciences Corp Put Options Transaction History

Nantahala Capital Management, LLC

13 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	SELL	$72.5 - $100.68 $10.9 Million - $15.1 Million	-150,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$90.24 - $124.05 $4.51 Million - $6.2 Million	50,000 Added 50.0%	150,000 $14.3 Million
Q2 2021 Aug 16, 2021	SELL	$93.66 - $139.27 $9.37 Million - $13.9 Million	-100,000 Reduced 50.0%	100,000 $12.4 Million
Q1 2021 May 14, 2021	BUY	$116.57 - $155.01 $5.83 Million - $7.75 Million	50,000 Added 33.33%	200,000 $26.4 Million
Q1 2020 May 14, 2020	SELL	$37.9 - $104.44 $9.78 Million - $26.9 Million	-258,000 Reduced 63.24%	150,000 $8.7 Million
Q4 2019 Feb 14, 2020	SELL	$77.66 - $99.74 $75 Million - $96.4 Million	-966,200 Reduced 70.31%	408,000 $37.7 Million
Q3 2019 Nov 14, 2019	BUY	$90.37 - $122.49 $7.05 Million - $9.55 Million	78,000 Added 6.02%	1,374,200 $124 Million
Q1 2019 May 15, 2019	BUY	$61.98 - $96.5 $11.5 Million - $18 Million	186,200 Added 16.77%	1,296,200 $112 Million
Q4 2018 Feb 14, 2019	SELL	$56.04 - $82.66 $105 Million - $154 Million	-1,868,800 Reduced 62.74%	1,110,000 $70 Million
Q3 2018 Nov 14, 2018	BUY	$48.29 - $80.6 $53.6 Million - $89.5 Million	1,110,000 Added 59.4%	2,978,800 $235 Million
Q2 2018 Aug 14, 2018	SELL	$37.84 - $69.96 $1.18 Million - $2.18 Million	-31,200 Reduced 1.64%	1,868,800 $112 Million
Q1 2018 May 15, 2018	SELL	$39.82 - $57.53 $7.96 Million - $11.5 Million	-200,000 Reduced 9.52%	1,900,000 $76.6 Million
Q3 2017 Nov 14, 2017	BUY	$37.05 - $47.12 $77.8 Million - $99 Million	2,100,000	2,100,000 $99 Million

672

164M

4.25M

1.89M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $8.72B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nantahala Capital Management, LLC with notifications on news.